Cell-Bank Construction
Tiered master and working cell banks under low-passage control ensure consistent, traceable sourcing.
From upstream cell banks to downstream release testing, Tonigen runs a full-process GMP exosome production and quality-control platform that delivers stable, traceable, and scalable raw-material supply for brands.
Tiered master and working cell banks under low-passage control ensure consistent, traceable sourcing.
Serum-free culture up to 8,000L with in-line monitoring enriches high-activity exosomes at scale.
Third-generation tangential-flow filtration strips host protein and free nucleic acid to 99.4% purity.
Custom lyophilization curves and cryoprotectant systems preserve particle size and membrane activity.
Grade-A aseptic filling inside the clean room supports injectable, lyophilized, and liquid formats.
Per-batch characterization with sterility and endotoxin testing, released only with COA and third-party reports.
Particle distribution is concentrated around 30-150nm with CD9 / CD63 / CD81 positivity and HPLC purity >= 99%.
Supports loading, lyophilization, blends, and co-branded formulation from pilot batches to scaled production.
GMP clean-room manufacturing with ISO 13485 / CE / FDA Registered systems and batch-level COA package.
8,000L annual culture system capacity supports kilogram-level material supply and low-MOQ evaluation.
Each batch is characterized around particle size, surface markers, purity, endotoxin, and sterility, with COA and third-party reports so customers can evaluate and onboard with confidence.
Get Quote →Quality and compliance systems span GMP / ISO 13485 / CE / FDA, with end-to-end traceability from raw material to delivery that lowers market-entry barriers for global customers.
Share your application and MOQ requirements. Within 48 hours, you will receive a tailored quotation, COA package, and sample-shipping plan.